Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
| Novartis Pharmaceuticals Corporation |
| Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc., Torrent Pharmaceuticals Ltd., Biocon Pharma, Inc., Biocon Pharma Limited, Lupin Atlantis Holdings, S.A., Biocon Limited, Laurus Labs Limited, Crystal Pharmaceutical (Suzhou) Co., Ltd., S&B Pharma, Inc., Alkem Laboratories Ltd., Aurobindo Pharma Ltd., Torrent Pharma Inc., Teva Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Inc., Nanjing Noratech Pharmaceutical Co., Limited, Lupin Limited and Laurus Generics Inc. |
| 1:2019cv01979 |
| October 17, 2019 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 7, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 26
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Torrent Pharmaceuticals Ltd. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 25
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Torrent Pharma Inc. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 24
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Teva Pharmaceuticals USA, Inc. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 23
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Nanjing Noratech Pharmaceutical Co., Limited waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 22
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Pharmaceuticals, Inc. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 21
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Limited waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 20
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Inc. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 19
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Lupin Atlantis Holdings, S.A. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 18
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Laurus Labs Limited waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 17
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Laurus Generics Inc. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 16
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Crystal Pharmaceutical (Suzhou) Co., Ltd. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 15
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Biocon Pharma Limited waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 14
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Biocon Pharma, Inc. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 13
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Biocon Limited waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 12
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Aurobindo Pharma USA Inc. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 11
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Aurobindo Pharma Ltd. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Filing 10
WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Alkem Laboratories Ltd. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel)
|
|
Pro Hac Vice Attorney Dmitry V. Shelhoff for Torrent Pharma Inc. and Torrent Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
|
|
SO ORDERED, re #9 STIPULATION and [Proposed] Order to Extend Deadline for Laurus Labs Limited and Laurus Generics Inc.'s Response to the Complaint filed by Novartis Pharmaceuticals Corporation. Signed by Judge Leonard P. Stark on 12/11/19. (ntl)
|
|
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff. Ph.D. filed by Torrent Pharmaceuticals Ltd., Torrent Pharma Inc. Signed by Judge Leonard P. Stark on 12/11/19. (ntl)
|
|
Filing 9
STIPULATION and [Proposed] Order to Extend Deadline for Laurus Labs Limited and Laurus Generics Inc.'s Response to the Complaint by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
|
|
Filing 8
MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff. Ph.D. - filed by Torrent Pharma Inc., Torrent Pharmaceuticals Ltd.. (Rutter, Jennifer)
|
|
SO ORDERED, re #7 STIPULATION and Order Dismissing S&B Pharma, Inc. Without Prejudice and Amending Caption to Reflect Same -- Party S&B Pharma, Inc. terminated. Signed by Judge Leonard P. Stark on 12/2/19. (ntl)
|
|
SO ORDERED, re #6 Stipulation and Order -- Party Teva Pharmaceutical Industries Ltd. terminated. Signed by Judge Leonard P. Stark on 11/25/19. (ntl)
|
|
Filing 7
STIPULATION and Order Dismissing S&B Pharma, Inc. Without Prejudice and Amending Caption to Reflect Same by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
|
|
Filing 6
STIPULATION and [Proposed] Order by Novartis Pharmaceuticals Corporation. (Silver, Daniel)
|
|
Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
|
|
No Summons Issued. (myr)
|
|
Filing 5
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (myr)
|
|
Filing 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659 ;8,796,331 ;8,877,938 ;9,388,134. (myr)
|
|
Filing 3
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached. Stay Deadline: See Attached. (myr)
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr)
|
|
Filing 1
COMPLAINT filed against Alkem Laboratories Ltd., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd., Laurus Generics Inc., Laurus Labs Limited, Lupin Atlantis Holdings, S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc., Nanjing Noratech Pharmaceutical Co., Limited, S&B Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-2757861.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(myr)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
